670 related articles for article (PubMed ID: 32782018)
21. Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2.
Hinson SR; Roemer SF; Lucchinetti CF; Fryer JP; Kryzer TJ; Chamberlain JL; Howe CL; Pittock SJ; Lennon VA
J Exp Med; 2008 Oct; 205(11):2473-81. PubMed ID: 18838545
[TBL] [Abstract][Full Text] [Related]
22. Cytoprotective IgG antibodies in sera from a subset of patients with AQP4-IgG seropositive neuromyelitis optica spectrum disorder.
Tradtrantip L; Yeaman MR; Verkman AS
Sci Rep; 2021 Nov; 11(1):21962. PubMed ID: 34753987
[TBL] [Abstract][Full Text] [Related]
23. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
Tao S; Zhang Y; Ye H; Guo D
Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
[TBL] [Abstract][Full Text] [Related]
24. Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G.
Yao X; Verkman AS
Acta Neuropathol Commun; 2017 Feb; 5(1):15. PubMed ID: 28212662
[TBL] [Abstract][Full Text] [Related]
25. Experimental animal models of aquaporin-4-IgG-seropositive neuromyelitis optica spectrum disorders: progress and shortcomings.
Duan T; Verkman AS
Brain Pathol; 2020 Jan; 30(1):13-25. PubMed ID: 31587392
[TBL] [Abstract][Full Text] [Related]
26. Spinal cord lesions and atrophy in NMOSD with AQP4-IgG and MOG-IgG associated autoimmunity.
Chien C; Scheel M; Schmitz-Hübsch T; Borisow N; Ruprecht K; Bellmann-Strobl J; Paul F; Brandt AU
Mult Scler; 2019 Dec; 25(14):1926-1936. PubMed ID: 30475082
[TBL] [Abstract][Full Text] [Related]
27. Structural and visual functional deficits in a rat model of neuromyelitis optica spectrum disorders related optic neuritis.
Zhang Y; Bao Y; Qiu W; Peng L; Fang L; Xu Y; Yang H
Exp Eye Res; 2018 Oct; 175():124-132. PubMed ID: 29913164
[TBL] [Abstract][Full Text] [Related]
28. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
Tzartos JS; Stergiou C; Kilidireas K; Zisimopoulou P; Thomaidis T; Tzartos SJ
PLoS One; 2013; 8(9):e74773. PubMed ID: 24086369
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA alleviates brain damage in a mouse model of neuromyelitis optica spectrum disorder by inducing neutrophil apoptosis.
Gong Y; Zhang YL; Wang Z; Song HH; Liu YC; Lv AW; Tian LL; Zhu WL; Fu Y; Ding XL; Cui LJ; Yan YP
J Neuroinflammation; 2020 Jun; 17(1):198. PubMed ID: 32586353
[TBL] [Abstract][Full Text] [Related]
30. Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link.
Jarius S; Wildemann B
Med Hypotheses; 2013 Dec; 81(6):1090-5. PubMed ID: 24182872
[TBL] [Abstract][Full Text] [Related]
31. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor.
Hinson SR; Clift IC; Luo N; Kryzer TJ; Lennon VA
Proc Natl Acad Sci U S A; 2017 May; 114(21):5491-5496. PubMed ID: 28461494
[TBL] [Abstract][Full Text] [Related]
32. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
Wu Y; Zhong L; Geng J
Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
[TBL] [Abstract][Full Text] [Related]
33. The protective effect of Angiotensin AT2-receptor stimulation in Neuromyelitis optica spectrum disorder is independent of astrocyte-derived BDNF.
Khorooshi R; Marczynska J; Dubik M; Dieu RS; Sørensen SF; Montanana-Rosell R; Limburg HL; Tygesen C; Asgari N; Steckelings UM; Owens T
Mult Scler Relat Disord; 2021 Aug; 53():103033. PubMed ID: 34090131
[TBL] [Abstract][Full Text] [Related]
34. Clinical and paraclinical profile of neuromyelitis optic spectrum disorder in a peruvian cohort.
Castro-Suarez S; Guevara-Silva E; Osorio-Marcatinco V; Alvarez-Toledo K; Meza-Vega M; Caparó-Zamalloa C
Mult Scler Relat Disord; 2022 Aug; 64():103919. PubMed ID: 35691236
[TBL] [Abstract][Full Text] [Related]
35. Low Frequency Ultrasound With Injection of NMO-IgG and Complement Produces Lesions Different From Experimental Autoimmune Encephalomyelitis Mice.
Xiang W; Xie C; Luo J; Zhang W; Zhao X; Yang H; Cai Y; Ding J; Wang Y; Hao Y; Zhang Y; Guan Y
Front Immunol; 2021; 12():727750. PubMed ID: 34721390
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Hinson SR; Lennon VA; Pittock SJ
Handb Clin Neurol; 2016; 133():377-403. PubMed ID: 27112688
[TBL] [Abstract][Full Text] [Related]
37. Pathogenic antibodies to AQP4: Neuromyelitis optica spectrum disorder (NMOSD).
Wright SK; Wassmer E; Vincent A
Biochim Biophys Acta Biomembr; 2021 Dec; 1863(12):183772. PubMed ID: 34509490
[TBL] [Abstract][Full Text] [Related]
38. The intrinsic pathogenic role of autoantibodies to aquaporin 4 mediating spinal cord disease in a rat passive-transfer model.
Geis C; Ritter C; Ruschil C; Weishaupt A; Grünewald B; Stoll G; Holmoy T; Misu T; Fujihara K; Hemmer B; Stadelmann C; Bennett JL; Sommer C; Toyka KV
Exp Neurol; 2015 Mar; 265():8-21. PubMed ID: 25542977
[TBL] [Abstract][Full Text] [Related]
39. [Recent progress in multiple sclerosis research: astrocytopathy in demyelinating diseases].
Kira J
Rinsho Shinkeigaku; 2010 Nov; 50(11):788-93. PubMed ID: 21921443
[TBL] [Abstract][Full Text] [Related]
40. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
